Abstract
The purpose of this study was to determine the prevalence of antibodies to hepatitis A, B and C in persons with intellectual disability in residential care in Israel and especially to determine the need for immunisation against hepatitis A. Four residential care centres were chosen from 53 centres housing 6022 persons. A total of 251 participants was tested and the prevalence of anti-hepatitis A virus was 91%, of hepatitis B surface antigen was 5.2%, its corresponding anti-HBs was 57% and of anti-hepatitis C virus was 0.8%. It is concluded that active immunisation against hepatitis B should be continued in this population, but only each new person who enters the residential care centres from home should be vaccinated against hepatitis A.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Intellectual and Developmental Disability
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
